Abstract
The worldwide prevalence of diabetes mellitus is projected to reach 5.4% (300 million individuals) by 2025, and the evolving pandemic of childhood obesity in Western countries has caused a significant increase in insulin resistance and type 2 diabetes. The potential societal impact is enormous, and growing appreciation of the scale of the problem is reflected in increasingly frequent public pronouncements by Western political leaders. There is an urgent need to develop and deploy systems for preventing the development of diabetes in individuals at risk, and for effective delivery of complex care to those who develop the condition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
